Exact Sciences
EXAS
#1715
Rank
A$15.12 B
Marketcap
$81.72
Share price
0.70%
Change (1 day)
-17.71%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of September 2024 : A$1.57 Billion

According to Exact Sciences's latest financial reports the company has A$1.57 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$1.14 B22.89%
2022-12-31A$0.92 B-34.65%
2021-12-31A$1.42 B-40.6%
2020-12-31A$2.39 B417.64%
2019-12-31A$0.46 B-71.03%
2018-12-31A$1.59 B193.33%
2017-12-31A$0.54 B26.05%
2016-12-31A$0.43 B2.45%
2015-12-31A$0.42 B21.93%
2014-12-31A$0.34 B131.26%
2013-12-31A$0.14 B43.59%
2012-12-31A$0.10 B14.27%
2011-12-31A$91.05 M-3.07%
2010-12-31A$93.93 M246.85%
2009-12-31A$27.08 M287.01%
2008-12-31A$6.99 M-51.39%
2007-12-31A$14.39 M-46.15%
2006-12-31A$26.73 M-42.67%
2005-12-31A$46.62 M-28.23%
2004-12-31A$64.97 M73.68%
2003-12-31A$37.41 M-51.93%
2002-12-31A$77.82 M-30.13%
2001-12-31A$0.11 B135.26%
2000-12-31A$47.34 M775.53%
1999-12-31A$5.4 M-62.49%
1998-12-31A$14.41 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.14 B-90.47%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.42 B-73.16%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.21 M-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.21 B 613.34%๐Ÿ‡ซ๐Ÿ‡ท France